These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 8706592)

  • 21. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of macrolides: clarithromycin in perspective.
    Neu HC
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():1-9. PubMed ID: 1827094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulary management of macrolide antibiotics.
    Guay DR
    Pharmacoeconomics; 1995 Dec; 8(6):491-512. PubMed ID: 10160079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of macrolide antibiotics.
    Williams JD; Sefton AM
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():11-26. PubMed ID: 8478301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrolide antibiotics.
    Pallasch TJ
    Dent Today; 1997 Nov; 16(11):72, 74-5, 78-9. PubMed ID: 9560736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistant respiratory pathogens and extended-spectrum antibiotics.
    Pichichero ME
    Am Fam Physician; 1995 Nov; 52(6):1739-46. PubMed ID: 7484684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of the new macrolides, azalides, and streptogramins in pediatrics.
    Adam D
    J Chemother; 1992 Dec; 4(6):371-5. PubMed ID: 1337554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The newer macrolides. Azithromycin and clarithromycin.
    Zuckerman JM; Kaye KM
    Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dental therapeutic indications for the newer long-acting macrolide antibiotics.
    Moore PA
    J Am Dent Assoc; 1999 Sep; 130(9):1341-3. PubMed ID: 10492541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new macrolides: expanding the ways in antibiotic treatment.
    Avilés Santa ML; Ramírez-Ronda CH
    Bol Asoc Med P R; 1992 Jan; 84(1):21-5. PubMed ID: 1503585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
    Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
    Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of macrolides in the treatment of respiratory tract infections in children].
    Floret D
    Arch Pediatr; 1995 Dec; 2(12):1184-91. PubMed ID: 8548000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
    J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
    Bahal N; Nahata MC
    Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The macrolide antibiotic renaissance.
    Dinos GP
    Br J Pharmacol; 2017 Sep; 174(18):2967-2983. PubMed ID: 28664582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study on azithromycin in 10% fine granules and 100mg capsules in the field of pediatrics].
    Motohiro T; Nagai K; Yamada S; Tsumura N; Yamada T; Oda K; Sakata Y; Kato H; Gakuen Y; Imai S; Sasaki H; Morita J; Ikezawa S; Matsuo Y; Yamashita Y; Aramaki M; Araki H; Yasuoka C; Hayashi M; Ono E; Hashimoto N; Kubota K; Kawakami A; Toyoda A; Wada M
    Jpn J Antibiot; 1997 Mar; 50(3):272-97. PubMed ID: 9634360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future role and importance of macrolides.
    Ball P
    J Hosp Infect; 1991 Sep; 19 Suppl A():47-59. PubMed ID: 1684983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Macrolides: indications in 1997].
    Bouhour D; Peyramond D
    Presse Med; 1997 Mar; 26 Suppl 2():22-6. PubMed ID: 9113049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.